BOSTON—Barbara Weber, the Chief Executive Officer of Tango Therapeutics, Inc. (NASDAQ:TNGX), a $350 million market cap biotech company, recently sold a portion of her holdings in the company.

Gladstone Institutes hopes to buy 103,400 square feet of life sciences research offices near its hub in San Francisco’s ...

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has updated employment agreements with key executive officers, including ...

In the last few days of the Biden Administration, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) issued a flurry of ...

BIS issued an Interim Final Rule that amends the Export Administration Regulation (EAR) to address dual use export ...

An immigrant entrepreneur, Andrea Pais cofounded Novel Microdevices by figuring it out as she went along — and learning where to find support.

Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.

Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...

“Farm Bureau applauds Mexico’s President Claudia Sheinbaum for repealing her country’s ban on biotech corn imports from ...

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Old Dominion Freight Line beat analyst's revenue projections in the fourth quarter of 2024 despite a 7% drop in revenue that ...